This research study was conducted on 100,000 participants including both HIV and non-HIV patients, aged around 48 years on an average. The results were published in the Journal of the American Heart Association where the participants with higher levels of bilirubin had 76% risk for cardiovascular diseases as same as the group with the lower bilirubin levels.
In a major breakthrough in the medical field, one of the world’s most dreadful viruses could possibly treat deadly brain tumors (glioblastoma). The survival chance turned out to be better than expected especially for patients who were administered the genetically modified poliovirus.
Telemedicine services are gaining entry into Japanese hospitals. Royal Philips recently announced its deal with Showa University in Japan in order to launch the first telemedicine intensive care program (eICU) at Showa Koto Toyosu Hospital and Showa University Hospital. This program will reduce mortality rates and increase savings as well as case volume.
A report was issued by the World Health Organization (WHO) recently that the number of people receiving hepatitis C cures was increased from 1 million in 2015 to 1.5 million in 2016. Previously, only a small number of countries took part in hepatitis C treatments.
Johnson & Johnson has once again won in its appeals campaign against talcum powder verdicts. Last year, the company had secured two reversals. In this year, the Missouri Court of Appeals reversed another verdict in Gloria Ristesund’s case worth $55 million, where the court lacked jurisdiction.
Appthority, the mobile app security firm revealed that a security threat affecting more than 3,000 mobile apps exposes around 4 million protected health records such as prescription details and sensitive chat messages.
The premarket approval of Pulmonx’s Zephyr Endobronchial Valve to treat severe emphysema has green-lighted by the FDA. Zephyr is a pencil eraser-sized device delivered directly to the lung in a minimally invasive procedure. After the successful delivery, the device stops air from entering diseased parts of the lung during breathing. This mechanism prevents the air from getting trapped by damaged alveoli and stops the breathing difficulties.
This app uses a smartphone camera, computer vision algorithms and machine learning tools to assess bilirubin levels in the white part of the eye named sclera since jaundice is considered as one of the earliest symptoms of pancreatic cancer. The eyes and the skin become yellow colored due to the accumulation of bilirubin in the blood caused by jaundice.
One such a research team is from Newcastle University where they have invented a 3D bioprint cornea, in order to control and focus the entry of light into the eye. By using a simple 3D bio-printer, the team united healthy corneal stem cells using hydration and alginate to produce ’bio-ink’. It is a simple solution used to replicate a human embryo form within 10 minutes.
Hepatitis is considered as the seventh leading cause of death throughout the world, where half of the deaths occur due to hepatitis B viral infection. Early cost-effective diagnosis could help in treating the affected patients without any delay.
your submission has already been received.
Please enter a valid Email address！
The most relevant industry news & insight will be sent to you every two weeks.